Natera

Natera is a global leader in cell-free DNA (cfDNA) testing, specializing in reproductive health, oncology, and organ transplantation. The company offers advanced genetic testing services such as non-invasive prenatal testing, preimplantation genetic diagnosis, and cancer diagnostics using circulating tumor DNA (ctDNA). With its proprietary Constellation platform, Natera provides clinicians with cutting-edge tools to manage genetic information, improve patient outcomes, and support precision medicine. Natera’s mission is to make personalized genetic testing accessible and affordable, helping to improve the quality of care worldwide. The company's tests are utilized by healthcare providers globally, and its dedication to advancing genetic diagnostics is supported by strong ethical standards and social responsibility initiatives. Natera also has a commitment to diversity and sustainability, ensuring that its solutions contribute to a healthier future for all.